Sunmax Biotechnology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	711.59	775.47	854.69	589.3	602.55
Short-Term Investments	-	90	107.1	227.37	76.79
Cash & Short-Term Investments	711.59	865.47	961.79	816.67	679.34
Cash Growth	-17.78%	-10.02%	17.77%	20.21%	-25.31%
Accounts Receivable	2.21	2.54	2.55	1.94	3.72
Other Receivables	0.72	26.07	6.84	1.37	4.71
Receivables	2.93	28.61	9.39	3.3	8.43
Inventory	152.66	157.36	93.67	73.79	54.74
Other Current Assets	275.9	41.08	14.08	11.81	45.06
Total Current Assets	1,143	1,093	1,079	905.58	787.57
Property, Plant & Equipment	911.64	939.2	904.32	604.39	485.56
Long-Term Investments	-	-	-	10.3	17.18
Other Intangible Assets	9.75	6.4	5.06	3.84	3.84
Long-Term Deferred Tax Assets	28.89	37.71	53.39	20.76	17.32
Other Long-Term Assets	30	19.15	117.33	248.41	172.55
Total Assets	2,123	2,095	2,159	1,793	1,484
Accounts Payable	7.25	18.27	11.98	21.77	14.95
Current Portion of Leases	25.47	23.28	24.24	13.27	32.28
Current Income Taxes Payable	72.08	67.76	89.03	82.94	70.84
Current Unearned Revenue	22.05	73.85	202.57	60.09	122.95
Other Current Liabilities	166.91	145.75	129.62	147.93	92.93
Total Current Liabilities	293.76	328.91	457.43	326	333.95
Long-Term Leases	93.87	121.94	144.78	49.82	66.9
Long-Term Deferred Tax Liabilities	91.02	103.06	105.19	57.16	22.16
Other Long-Term Liabilities	26.95	28.23	25.59	35.02	37.43
Total Liabilities	505.6	582.13	732.99	468	460.44
Common Stock	544.63	544.63	544.63	544.63	544.63
Additional Paid-In Capital	3.65	3.65	3.65	3.65	25.44
Retained Earnings	1,067	973.11	892.8	778.61	460.46
Comprehensive Income & Other	2.39	-8.56	-15.04	-1.62	-6.95
Shareholders' Equity	1,618	1,513	1,426	1,325	1,024
Total Liabilities & Equity	2,123	2,095	2,159	1,793	1,484
Total Debt	119.33	145.21	169.02	63.09	99.18
Net Cash (Debt)	592.26	720.26	792.78	753.58	580.16
Net Cash Growth	-17.77%	-9.15%	5.20%	29.89%	-25.59%
Net Cash Per Share	10.86	13.21	14.54	13.82	10.64
Filing Date Shares Outstanding	54.39	54.46	54.46	54.46	54.46
Total Common Shares Outstanding	54.39	54.46	54.46	54.46	54.46
Working Capital	849.33	763.6	621.51	579.57	453.62
Book Value Per Share	29.74	27.78	26.18	24.33	18.79
Tangible Book Value	1,608	1,506	1,421	1,321	1,020
Tangible Book Value Per Share	29.56	27.66	26.09	24.26	18.72
Land	-	64.9	-	-	-
Buildings	-	517.01	487.13	482.71	-
Machinery	-	343.25	293.4	82.42	62.95
Construction In Progress	-	0.3	17.79	-	331.26
Leasehold Improvements	-	45.44	44.01	44.79	44.4

Source: S&P Global Market Intelligence. Standard template. Financial Sources.